Epilepsy Drug
- All
- News
- Videos
-
Another Drug From Delhi Hospitals Found To Be Sub-Standard: Lt Governor's Office
Days after Delhi Lt Governor VK Saxena referred a matter pertaining to drugs failing quality standard tests to CBI, Raj Niwas officials on Wednesday reported another medicine used for treating seizures and epilepsy turning out to be spurious.
-
Stress And Epilepsy: Expert Explains The Link
Epilepsy, when untreated and ignored, can become critical and increase the risk of premature death in patients.
-
Zydus Gets US Regulator's Approval To Market Generic Epilepsy Drug
The drug will be manufactured at the group's formulation manufacturing facility at Ahmedabad SEZ, Zydus said in a statement.
-
National Epilepsy Day 2023: Know The Common Signs And Symptoms Of Epilepsy
National Epilepsy Day 2023: The neurological condition epilepsy is characterised by irregular brain activity that results in seizures or episodes.
-
This Electronic Device Could Stop Epileptic Seizures
The researchers have found that seizures could be prevented with relatively small doses of drug representing less than 1% of the total amount of drug loaded into the device. This means the device should be able to operate for extended periods without needing to be refilled.
-
Food and Drug Administration (FDA) Approves First Marijuana-Derived Drug For Epilepsy
On monday, The Food and Drug Administration approved the first drug derived from marijuana. This drug can be used to treat two rare and severe forms of childhood epilepsy.
-
US Approves First Marijuana-Derived Drug To Fight Epilepsy
US regulators on Monday approved the first marijuana-derived drug ever to hit the US market, Epidiolex, which will be used to treat two rare and severe forms of childhood epilepsy.
-
First Marijuana-Derived Drug Is On The Verge Of Getting Approval In US
Approval of the medication, intended for childhood epilepsy, could lead to reclassification of cannabidiol, or CBD.
-
Britain Fines Pfizer Record $107 Million For Huge Drug Price Hike
Britain's competition watchdog said on Wednesday it had fined Pfizer a record 84.2 million pounds ($106.54 million) for ramping up the cost of an epilepsy drug by as much as 2,600 percent.
-
Epilepsy Drugs May Increase Birth Defect Risk: Study
London: Exposure to certain anti-epileptic drugs (AEDs) during pregnancy may put women at higher risk of having a child with a malformation, or birth defect, says a study. The study based on systematic review of 50 published studies found that exposure in the womb to the anti-epileptic drug sodium valproate was associated with a 10 per cent chance ...
-
SPARC and Sun Pharma Ink Licensing Pact For Epilepsy Drug
Sun Pharma Advanced Research Company (SPARC) and its parent Sun Pharma have entered into a licensing arrangement for its Elepsia tablets, used in the treatment of epilepsy, in the US market for an up-front payment of $10 million.
-
Jubilant Life Sciences Shares Jump On Approval For Epilepsy Injection
With this approval, Jubilant Life Sciences' total Abbreviated New Drug Application (ANDA) approvals rose to 517 in various regions globally, the company said.
-
Drug Price Controller Fixes Price Of 70 Drug Formulation Packs
Last month, NPPA had fixed the ceiling price of as many as 103 drug formulation packs, including those used for treating HIV/AIDS, bacterial infections, tuberculosis, high blood pressure, epilepsy, Hepatitis C and diabetes.
-
Glenmark Gets Tentative Nod From FDA For Epilepsy Drug
Glenmark Pharmaceuticals today said it has received tentative approval from the US health regulator for its generic version of Vimpat Oral Solution, used in treatment of epilepsy.
-
450 Cases Of Birth Defects From Anti-Epilepsy Drug In France: Health Officials
A common drug used to treat epilepsy has caused congenital defects in around 450 babies in France who were exposed to the medication before birth in the uterus, according to an estimate by health authorities published on Tuesday.
-
Another Drug From Delhi Hospitals Found To Be Sub-Standard: Lt Governor's Office
Days after Delhi Lt Governor VK Saxena referred a matter pertaining to drugs failing quality standard tests to CBI, Raj Niwas officials on Wednesday reported another medicine used for treating seizures and epilepsy turning out to be spurious.
-
Stress And Epilepsy: Expert Explains The Link
Epilepsy, when untreated and ignored, can become critical and increase the risk of premature death in patients.
-
Zydus Gets US Regulator's Approval To Market Generic Epilepsy Drug
The drug will be manufactured at the group's formulation manufacturing facility at Ahmedabad SEZ, Zydus said in a statement.
-
National Epilepsy Day 2023: Know The Common Signs And Symptoms Of Epilepsy
National Epilepsy Day 2023: The neurological condition epilepsy is characterised by irregular brain activity that results in seizures or episodes.
-
This Electronic Device Could Stop Epileptic Seizures
The researchers have found that seizures could be prevented with relatively small doses of drug representing less than 1% of the total amount of drug loaded into the device. This means the device should be able to operate for extended periods without needing to be refilled.
-
Food and Drug Administration (FDA) Approves First Marijuana-Derived Drug For Epilepsy
On monday, The Food and Drug Administration approved the first drug derived from marijuana. This drug can be used to treat two rare and severe forms of childhood epilepsy.
-
US Approves First Marijuana-Derived Drug To Fight Epilepsy
US regulators on Monday approved the first marijuana-derived drug ever to hit the US market, Epidiolex, which will be used to treat two rare and severe forms of childhood epilepsy.
-
First Marijuana-Derived Drug Is On The Verge Of Getting Approval In US
Approval of the medication, intended for childhood epilepsy, could lead to reclassification of cannabidiol, or CBD.
-
Britain Fines Pfizer Record $107 Million For Huge Drug Price Hike
Britain's competition watchdog said on Wednesday it had fined Pfizer a record 84.2 million pounds ($106.54 million) for ramping up the cost of an epilepsy drug by as much as 2,600 percent.
-
Epilepsy Drugs May Increase Birth Defect Risk: Study
London: Exposure to certain anti-epileptic drugs (AEDs) during pregnancy may put women at higher risk of having a child with a malformation, or birth defect, says a study. The study based on systematic review of 50 published studies found that exposure in the womb to the anti-epileptic drug sodium valproate was associated with a 10 per cent chance ...
-
SPARC and Sun Pharma Ink Licensing Pact For Epilepsy Drug
Sun Pharma Advanced Research Company (SPARC) and its parent Sun Pharma have entered into a licensing arrangement for its Elepsia tablets, used in the treatment of epilepsy, in the US market for an up-front payment of $10 million.
-
Jubilant Life Sciences Shares Jump On Approval For Epilepsy Injection
With this approval, Jubilant Life Sciences' total Abbreviated New Drug Application (ANDA) approvals rose to 517 in various regions globally, the company said.
-
Drug Price Controller Fixes Price Of 70 Drug Formulation Packs
Last month, NPPA had fixed the ceiling price of as many as 103 drug formulation packs, including those used for treating HIV/AIDS, bacterial infections, tuberculosis, high blood pressure, epilepsy, Hepatitis C and diabetes.
-
Glenmark Gets Tentative Nod From FDA For Epilepsy Drug
Glenmark Pharmaceuticals today said it has received tentative approval from the US health regulator for its generic version of Vimpat Oral Solution, used in treatment of epilepsy.
-
450 Cases Of Birth Defects From Anti-Epilepsy Drug In France: Health Officials
A common drug used to treat epilepsy has caused congenital defects in around 450 babies in France who were exposed to the medication before birth in the uterus, according to an estimate by health authorities published on Tuesday.
